Work

1203P Clinical correlations and long-term survival in PROTA: Platinum-resistant or refractory ovarian cancer treated with an oncolytic adenovirus encoding TNF and IL2 in combination with pembrolizumab

Year: 2025

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.1838

Authors: N. Ojala, J. Clubb, M.S. Block, J. Mäenpää, V. Arias, M. van der Heijden, S.A. Pakola, D.C.A. Quixabeira, T. Kudling, E. Jirovec, L. Haybout, T.V. Alanko, D. Adamo, S. Ramadan, J. Sormunen, J.T. Kononen, M.J. Chisamore, J.M. Santos, V. Cervera-Carrascon, A. Hemminki

Institutions: University of Helsinki, Mayo Clinic, Docrates Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri, European Commission, Jane ja Aatos Erkon Säätiö, Syöpäsäätiö

OpenAlex ID: W4415941994

FWCI:

Cites:

Cited by:

Related to: 10